Quidel Market Cap 2006-2020 | QDEL

Quidel market cap history and chart from 2006 to 2020. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Quidel market cap as of May 22, 2020 is $7.29B.
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $7.286B $0.535B
Quidel Corp. discovers, develops, manufactures and markets point-of-care, rapid diagnostic tests for detection of medical conditions and illnesses. These products provide accurate, rapid and cost-effective diagnostic information for acute and chronic conditions that affect women's health throughout the phases of their lives including reproductive status, pregnancy management and osteoporosis. Quidel also provides point-of-care diagnostics for infectious diseases, including influenza A and B, strep throat, H. pylori infection, chlamydia and infectious mononucleosis.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $161.796B 28.06
Medtronic (MDT) Ireland $126.941B 20.64
Stryker (SYK) United States $69.021B 22.40
Boston Scientific (BSX) United States $50.251B 23.63
Baxter (BAX) United States $44.091B 0.00
Lonza Group Ag (LZAGY) Switzerland $37.041B 0.00
Terumo (TRUMY) Japan $28.057B 0.00
EssilorLuxottica Societe Anonyme (ESLOY) France $26.322B 0.00
Zimmer Biomet Holdings (ZBH) United States $25.470B 16.03
ResMed (RMD) United States $23.342B 36.84
Smith & Nephew SNATS (SNN) United Kingdom $17.880B 0.00
Sunny Optical Technology (SNPTF) China $15.213B 0.00
Bio-Rad Laboratories (BIO) United States $14.007B 63.76
Insulet (PODD) United States $12.117B 1200.50
Shandong Weigao Medical Polymer (SHWGF) China $7.417B 0.00
Perrigo (PRGO) Ireland $7.399B 13.24
Canopy Growth (CGC) Canada $6.813B 0.00
Hill-Rom Holdings (HRC) United States $6.659B 18.77
GN STORE NORD (GNNDY) Denmark $6.590B 0.00
William Demant Holdings (WILYY) Denmark $6.417B 0.00
Haemonetics (HAE) United States $5.439B 32.67
ICU Medical (ICUI) United States $3.980B 29.03
GW Pharmaceuticals (GWPH) United Kingdom $3.925B 0.00
Agios Pharmaceuticals (AGIO) United States $3.636B 0.00
Neogen (NEOG) United States $3.523B 59.67
NuVasive (NUVA) United States $3.220B 25.86
Envista Holdings (NVST) United States $3.020B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.826B 0.00
TG Therapeutics (TGTX) United States $2.406B 0.00
National Vision Holdings (EYE) United States $2.037B 35.24
AtriCure (ATRC) United States $1.994B 0.00
Aurora Cannabis (ACB) Canada $1.624B 0.00
Cardiovascular Systems (CSII) United States $1.306B 0.00
MacroGenics (MGNX) United States $1.247B 0.00
NanoString Technologies (NSTG) United States $1.173B 0.00
Aphria (APHA) Canada $1.080B 0.00
Phibro Animal Health (PAHC) United States $1.001B 19.96
Cerus (CERS) United States $0.971B 0.00
OraSure Technologies (OSUR) United States $0.923B 185.88
InMode (INMD) Israel $0.838B 17.70
Omeros (OMER) United States $0.837B 0.00
PetIQ (PETQ) United States $0.818B 23.62
DFB Healthcare Acquisitions (AHCO) United States $0.756B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.726B 52.03
VAREX IMAGING (VREX) United States $0.684B 16.99
Quanterix (QTRX) United States $0.681B 0.00
Meridian Bioscience (VIVO) United States $0.635B 23.92
Zynex (ZYXI) United States $0.631B 63.33
Vapotherm (VAPO) United States $0.557B 0.00
Surmodics (SRDX) United States $0.505B 60.88
Lantheus Holdings (LNTH) United States $0.505B 10.16
LeMaitre Vascular (LMAT) United States $0.503B 28.67
Owens & Minor (OMI) United States $0.463B 12.25
Repro-Med Systems (KRMD) United States $0.387B 325.00
Cytosorbents (CTSO) United States $0.378B 0.00
Utah Medical Products (UTMD) United States $0.333B 24.16
BioLife Solutions (BLFS) United States $0.328B 145.91
Viemed Healthcare (VMD) United States $0.323B 28.90
Neptune Wellness Solutions (NEPT) Canada $0.290B 0.00
Organigram Holdings (OGI) Canada $0.290B 0.00
HEXO (HEXO) $0.256B 0.00
Female Health (VERU) United States $0.241B 0.00
Chimerix (CMRX) United States $0.207B 0.00
Chembio Diagnostics (CEMI) United States $0.191B 0.00
Exagen (XGN) United States $0.175B 0.00
Bovie Medical (APYX) United States $0.157B 0.00
Evolus (EOLS) United States $0.151B 0.00
Surface Oncology (SURF) United States $0.148B 0.00
Fonar (FONR) United States $0.148B 13.08
Rockwell Medical (RMTI) United States $0.146B 0.00
United Health Products (UEEC) United States $0.134B 0.00
Liberty Health Sciences (LHSIF) Canada $0.131B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.119B 0.00
MTech Acquisition (KERN) United States $0.119B 0.00
Brainsway (BWAY) Israel $0.089B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.077B 0.00
Capricor Therapeutics (CAPR) United States $0.077B 0.00
Wound Management Technologies (SMTI) United States $0.076B 0.00
Nephros (NEPH) United States $0.070B 0.00
United-Guardian (UG) United States $0.069B 16.01
GUARDION HEALTH (GHSI) United States $0.047B 0.00
Trinity Biotech (TRIB) Ireland $0.036B 0.00
ImmuCell (ICCC) United States $0.030B 0.00
NF Energy Saving (BIMI) China $0.026B 0.00
FSD PHARMA INC (HUGE) Canada $0.021B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.018B 0.00
Akers Biosciences Inc (AKER) United States $0.015B 0.00
Senestech (SNES) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.005B 0.00